Kinetics of Neutralizing Antibody Response Underscores Clinical COVID-19 Progression
Qing Lei(Huazhong University of Science and Technology), Xionglin Fan(Huazhong University of Science and Technology), Caizheng Yu(Huazhong University of Science and Technology), Yandi Zhang(Liaoning Normal University), Feng Wang(Tongji Hospital), Sun Ziyong(Tongji Hospital), Xiaosong Lin(Huazhong University of Science and Technology), Hongyan Hou(Tongji Hospital), Jo‐Lewis Banga Ndzouboukou(Huazhong University of Science and Technology), Hui Fu(Huazhong University of Science and Technology), Zongjie Yao(Huazhong University of Science and Technology)
Cited by 6
Related Papers
Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
|Cell|2020|802
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019
|Clinical & Translational Immunology|2020|415
Cohort Profile: The Dongfeng–Tongji cohort study of retired workers
|International Journal of Epidemiology|2012|295
Linear epitope landscape of the SARS-CoV-2 Spike protein constructed from 1,051 COVID-19 patients
|Cell Reports|2021|184
CRISPR/Cas9-Based Mutagenesis of Starch Biosynthetic Genes in Sweet Potato (Ipomoea Batatas) for the Improvement of Starch Quality
|International Journal of Molecular Sciences|2019|147